Poems

advertisement

Castle-POES disease successfully treated with

Rituximab

Nezam Torok , MD

PGY2

History :

A 42 year old African American Man

CC : Back pain , for 1 week

Nov 2008 : Pericardial effusion

Dec 2008 : Suspecion of sarcoidosis

PMH :

Social history

Smoker 30 PPY

 sexual dysfunction

Neurological : Motor function : power 4/5 lower limb –leg flexor and extensors as well as foot , bilaterally with diminished DTR and decreased sensation to touch , pain , and position , otherwise negative .

More lab tests :

HIV , HHV 8 negative

Normal or negative tests include : TFT ,

LH , FSH , testosterone ,ANA , ANCA ,

ACE ,RF , SS-A , SS-B , C3, C4, Hep B ,

Hep C ,PSA, vit B12 , APA .

SPE :

 increase in IgG 1950 mg/dL(normal 590-1540 mg/dL) mild increase in IgA 498 (normal 50-413mg/dL ) serum immunofixation polyclonal hypergammaglobulinemia with slightly excess lambda chains , kappa chains 1040 mg/dL ( normal 539 -1320 mg/dL) , and Lambda chains

690mg/dL (normal 285-673mg/dL ) with kappa /lambda ratio of 1,5 .

Normal architecture

Effaced architecture of the LN in castlemans disease , HE stain 4 X

Normal architecture of LN

Atrophic germinal centers

, HE stain 40X

Normal germinal center, containing larger lymphocytes undergoing activation

Atrophic germinal center and effaced architercture

Vascular proliferation ,10 X

Vascular proliferation 20 X

Vascular proliferation 40 X

 interleukin 6 level: 6 pg/ml (normal 0-5pg/ml)

 plasma Vascular Endothelial Growth factor level

(VEGF): 130 pg/ml (normal 6-86 pg/ml)

 normal interleukin 1.

Summary of findings

Osteosclerotic lesions

Neuropathy motor and sensory

Skin changes

Lymphadenopathy

History of pericardial effusion

Castlemans disease

High IL-6 and VEGF

Diagnosis is

Multicentric Castleman’s disease with features of

POEMS syndrome (Castle-

POES)!

Treatment

There is no standard treatment for this disorder and no randomized or quasi-randomized controlled clinical trials of treatment for POEMS syndrome exist in the available literature*

* Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, Mprotein, and skin changes) syndrome. Kuwabara S; Dispenzieri A; Arimura K;

Misawa S Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006828

How did we treat the patient

Rituximab

375/m2 , weekly for 4 weeks , then once every

2-3 months

How did the patient respond

Remarkable improvement in muscle power , able to function again

Fatigue resolved

Sexual function improved.

Dec PET scan activity at the scerotic bone lesions

No lymphadenopathy

BUT

VEGF was still at the same level .

 no change in skin lesions.

SPEP and immunofixation the same pattern

Investigational model

differential scanning calorimeter (DSC)

differential scanning calorimeter

(DSC

Our Patient

Control

The DST shows abnormal thermogram, which means there is abnomal molecular species present in the serum of the serum sample that interact in a significant way with one or more of the proteins in the serum

 it is different from electrophoresis technique that are sensitive to size and charge

What kind of protein , whats is the relation to immunofixation ?

“ Thinking is more interesting than knowing, but less interesting than looking

”.

References

Bradwick PA, Zvaifler NJ, Gill GN, et al. Plasma celldyscrasia with polyneuropathy, organomegaly,endocrinopathy, M protein and skin changes: the POEMSsyndrome.

Medicine 1980; 59: 311–322

Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood 2003;101:2496–506

Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 1984;34:712-20.

Shikama N, Isono A, Otsuka Y, Terano T, Hirai A .a case of POEMS syndrome with high concentration of IL-6 in pericardial fluid .

J Intern Med. 2001 Aug;250(2):170-3

Hashiguchi T, Arimura K, Matsumuro K, et al. Highly concentrated vascular endothelial growth factor in plateletsin Crow-Fukase syndrome. Muscle Nerve.

2000;23:1051-1056.

Soubrier M, Dubost JJ, Serre AF, et al. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis

Rheum. 1997;40:786-787

Joanne Shirine Allam, Cassie C. Kennedy, Timothy R. Aksamit and Angela Dispenzieri

. Pulmonary Manifestations in Patients With POEMS Syndrome. Chest 2008;133;969-

974

Download